We have previously demonstrated, using chimeric resistant MRL/lpr mice, that a fractionated total body irradiation (FTBI) (5 Gy ؋ 2 with a 4 h interval on the day before allogeneic bone marrow transplantation (BMT) ) is the best conditioning regimen for the treatment of autoimmune diseases in radiosensitive MRL/lpr mice. In the present study, using various standard strains of mice (not radiosensitive mice), we explore the best protocol for irradiation (doses and intervals) as the conditioning regimen for allogeneic BMT. Recipient mice were exposed to various irradiation regimens: a single total body irradiation (TBI) of 9.5 or 12 Gy and FTBI of (5+5) Gy to (7+7) Gy with a 1 to 24 h interval. The method generally utilized for humans ((2+2) Gy with a 4 h interval for 3 days (total 12 Gy)) was also used. One day after the last irradiation, donor BMCs from BALB/c, C3H, or C57BL/6 (B6) mice were transplanted into C3H or B6 mice. The irradiation protocol of (2+2) Gy for 3 days was found to be insufficient to enable the complete removal of recipient immunocompetent cells, since donor-reactive T cells were observed in the recipient spleens and many recipient-type NK and CD4 + cells were also detected in the recipient hematolymphoid tissues. In all the combinations, the highest survival rate was achieved in the recipients irradiated with (6+6) or (6.5+6.5) Gy with a 4 h interval. In the surviving mice, the hematolymphoid tissues had been fully reconstituted with donor cells. Bone Marrow Transplantation (2002) 30, 843-849. doi:10.1038/sj.bmt.1703766 Keywords: bone marrow transplantation; fractionated irradiation; reconstitution Irradiation has been used as an effective conditioning regimen for bone marrow transplantation (BMT), since it kills rapidly proliferating immunocompetent cells, particularly T
cells, and hemopoietic progenitor cells in the recipients. In the 1990s, fractionated total body irradiation (FTBI) became more common than single high-dose irradiation, since it has been reported that FTBI induces less idiopathic interstitial pneumonia, gastrointestinal injury and late cataract formation than single high-dose irradiation. Moreover, FTBI was found to be more effective for the treatment of solid tumors than single high-dose irradiation, since FTBI can effectively abrogate malignant cells that have reentered the mitotic cycle. Buchali et al 1 demonstrated that FTBI (2 Gy ϫ 6 with an 8 h interval) resulted in no severe immediate side-effects in a total of 162 patients. In contrast, there are some reports showing that FTBI is less effective in the treatment of malignant tumors, particularly leukemias, than single high-dose irradiation. 2, 3 We have previously demonstrated that allogeneic BMT can be used to treat both systemic and organ-specific autoimmune diseases, [4] [5] [6] [7] [8] and that autoimmune diseases are stem cell disorders. 5 The MRL/lpr mouse, an animal model for systemic lupus erythematosus (SLE), is known to be radiosensitive (particularly after the onset of the disease); almost all the mice die as a result of intestinal damage when irradiated with more than 8.5 Gy, and lower doses do not remove abnormal hemopoietic stem cells of MRL/lpr mice. 9, 10 Recently, we have found that 5 Gy ϫ 2 with a 4 h interval followed by intra-bone marrow (IBM)-BMT can rescue MRL/lpr mice with autoimmune diseases. 11 In the present study, we investigate using various combinations of standard strains of mice (not radiosensitive mice as recipients) whether the FTBI used in MRL/lpr mice is also effective in allogeneic BMT without engrafting a high number of donor BMCs, since it is important to know that the protocol is generally effective in various mouse combinations. ) and DBA/1 (H-2 q ) mice were purchased from Shizuoka Experimental Animal Laboratory (Shizuoka, Japan), and maintained in pathogen-free conditions in our animal facility. The mice were used at 8-10 weeks of age.
Materials and methods

Animals
Bone Marrow Transplantation
Antibodies FITC-, PE-or biotin-coupled anti-H-2 monoclonal antibodies (mAbs) (anti-H-2 b : clone AF6-88.5, anti-H-2 d : SF1-1.1, and anti-H-2 k : AF3-12.1 mAbs) and anti-lineage-specific mAbs (anti-CD4: clone GK15, anti-CD8:53.6.7, anti-B220:RA3-6B2, anti-Gr-1:RB6-8C5, anti-Mac-1:M1/70.5, and anti-pan-NK:DX5 mAbs) were purchased from PharMingen (San Diego, CA, USA) for analyses of surface phenotypes. Streptavidin-RED 670 (GIBCO, BRL, Grand Island, NY, USA) was used as the second stage reagent for all biotin-conjugated mAbs.
Irradiation
Recipient mice were placed in an acrylic container (28 cm diameter, 8 cm depth) in a continuous airflow between two opposing 137 Cs ␥-ray sources (Gamma cell 40; Nordion International, Kanata, Ontario, Canada). The mice were then exposed to various FTBI at a rate of 1.02 Gy/min before transplantation; two doses of 5, 5.5, 6, 6.5 or 7 Gy with a 1 to 24 h interval or six doses of 2 Gy (twice with a 4 h interval/day) for 3 days (total 12 Gy). Some recipient mice were irradiated with a single dose of 9.5 Gy or 12 Gy.
Bone marrow transplantation
Donor mice (BALB/c, B6 or C3H) were killed and bone marrow cells (BMCs) were collected from the tibias and femurs. BMCs were suspended in PBS containing 2% heatinactivated fetal bovine serum (FBS). One day after the last irradiation, the recipient mice were intravenously injected with 3 ϫ 10 6 BMCs from donors via the tail vein using a 27-gauge needle. The donor/recipient combinations were (BALB/c→C3H), (BALB/c→B6), (C3H→B6) or (B6→C3H). C3H mice are not radiosensitive when ordinary irradiation is carried out (a single high-dose of irradiation) or fractionated irradiation of middle doses (shown in the present experiments), since they can survive and hemopoiesis is reconstituted with donor cells, and the recovery pattern of hemopoiesis is not different from B6 mice. However, when irradiated with highly-fractionated low-dose irradiation, C3H mice show a different behavior from B6 mice (shown in the present experiments). In contrast, BALB/c mice are known to be very radiosensitive (Ͻ8.0 Gy). Therefore, B6 and C3H mice but not BALB/c mice were used as recipients.
Flow cytometric analyses
The recipient mice were bled 7 to 60 days after BMT and mononuclear cells collected using Lympholyte-M (Cedarlane, Ontario, Canada). In some experiments, both BMCs and spleen cells were collected from the recipient mice. The cells were stained for lineage markers and anti-H-2 mAbs. The stained cells were analyzed by a FACScan (Becton Dickinson, Mountain View, CA, USA).
Histological examination
Various tissues of the recipient mice were fixed with 10% formalin and sectioned at 2 m. The sections were stained with hematoxylin/eosin (HE).
Mixed lymphocyte reaction (MLR)
Spleen cells from the recipient mice were assessed for their ability to react with allogeneic spleen cells. The recipient spleen cells (responder: 3 ϫ 10 5 /well) were incubated in triplicate with irradiated (15 Gy) spleen cells (stimulator: 4 ϫ 10 5 /well) from untreated mice for 3 days in 96-well flat-bottom culture plates. The culture medium (RPMI) was supplemented with 10% FBS and 50 m 2-mercaptoethanol (2-ME). As a control, wells containing only responder cells were prepared. The incubated cells were pulsed with 3 HTdR for the last 18 h of the culture period.
Statistical analyses
The survival rate was analyzed using the log-rank test software, and the reconstitution rate was examined by the -square test on a Macintosh computer.
Each experiment was carried out three or more times and reproducible results were obtained. Therefore, representative data are shown in the Figures.
Results
Optimal interval of FTBI
We have recently shown that FTBI of (5+5) Gy with a 4 h interval as the conditioning regimen can be used to treat autoimmune diseases in radiosensitive MRL/lpr mice if IBM-BMT is carried out. 11 To analyze the optimal FTBI interval using standard strains of mice, C3H mice were irradiated with a 1 to 24 h interval with (5+5) Gy and engrafted with 3 ϫ10 6 BALB/c whole BMCs. The cell number (3 ϫ 10 6 ) was used for the following experiments, since only a moderate survival rate (50-80%) was observed when the mice were irradiated with a single high-dose irradiation (9.5 Gy) and then reconstituted with 3 ϫ 10 6 whole BMCs. As shown in Figure 1a , the survival rate decreased in (BALB/c→C3H) chimeras as the irradiation ((5+5) Gy) interval was extended. The mice died within 1 month when irradiated with a 14 to 24 h interval, but a 60-70% survival rate could be achieved with a 1 to 4 h interval and a 40% survival rate was obtained with an 8 h interval. There was no significant difference in the rates of graft failure in the 1 to 8 h interval groups (Figure 2a ). The rates of graft failure were calculated using the surviving mice 60 days after BMT. However, if all the treated mice were included in the calculation and the dead mice were considered as non-reconstituted mice, the difference between the 4 and 8 h interval groups was significant (P = 0.0303).
We next increased the radiation dose from (5+5) Gy to (6+6) Gy. Figure 1b shows the survival rates of the mice irradiated with (6+6) Gy. All the mice ((BALB/c→C3H) or (BALB/c→B6)) irradiated with 12 Gy (one shot) died within 52 days after BMT. The survival rates of both (BALB/c→C3H) and (BALB/c→B6) mice were lower in the 1 to 2 h interval groups than in the 4 to 24 h interval groups. The mice irradiated at an interval of 1 h developed cataracts 2 months after BMT, indicating that an interval of only 1 h results in severe side-effects. When the mice ) was also given to some mice. BALB/c BMCs (3 ϫ 10 6 ) were injected intravenously into the irradiated mice 24 h after the last irradiation. Survival was observed up to 60 days after BMT. (a) Statistically significant differences (P Ͻ 0.001) from 4 h interval group were observed in 14 and 24 h interval groups, respectively (the log-rank test). Other groups were not significantly different, compared with the 4 h interval group (n у 18/each group). (b) Significant differences from the 4 h interval group were observed in the 1 and 2 h interval groups, respectively. The 8 to 24 h interval groups were not significantly different compared with the 4 h interval group (n у 15/each group). *Ns, not significant. and B6 mice were irradiated with (5+5) or (6+6) Gy at various intervals. BALB/c BMCs (3 ϫ 10 6 ) were injected into the irradiated mice 24 h after the last irradiation. Sixty days later, recipient PBCs were collected and stained with anti-donor-and anti-recipient-type H-2 antibodies. The mice having more than 2% of recipient-type cells in PBCs were considered as graft failures (n у 8/each group). *Ns, not significant. **The survival rates were lower in these groups, and the few surviving mice were reconstituted completely with donor cells.
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were irradiated with an interval of 8 to 24 h, their survival rates were similar to the 4 h interval group. However, the percentage of graft failure was significantly smaller in the 4 h interval group (Figure 2b ). Since similar results were observed in both (BALB/c→B6) and (BALB/c→C3H) combinations, these observations seem to be a common phenomenon even if mouse combinations are changed.
The above results indicate that (6+6) Gy at the 4 h interval is so far the optimal regimen for allogeneic BMT.
Comparison of reconstitution and survival in mice irradiated with a single high dose or fractionated doses in various mouse combinations
To find the best irradiation dose, whole BMCs collected from BALB/c, C3H, and B6 mice were injected into recipient C3H or B6 mice exposed to various regimens: various fractionated doses (2, 5, 6, 6.5 or 7 Gy) with a 4 h interval or a single high dose (9.5 Gy). Their survival rates, which ranged up to 60 days, are shown in Figure 3 . Although the B6 mice treated with FTBI ((2+2) Gy for 3 days) showed good survival rates, all the hematolymphoid cells of the recipients were replaced by recipient-type cells due to complete graft rejection. In contrast, this strategy was lethal for recipient C3H mice due to graft failure. There was no significant difference between a single irradiation dose (9.5 Gy) and split (ϫ2) irradiation doses (5, 5.5, 6, 6.5 or 7 Gy), although the survival rate tended to be lower in the group irradiated with a single high dose. In all the combinations, the higher survival rates were obtained in the recipients irradiated with (6+6) to (6.5+6.5) Gy. The survival rate up to 60 days post transplantation is shown here because no death due to graft failure was observed thereafter. Figure 4 shows a typical FACS pattern of various hematolymphoid tissues in the (BALB/c→B6) mice irradiated with various doses. (BALB/c→B6) mice irradiated with (2+2) Gy for 3 days showed recipient-type hematolymphoid cells. However, almost complete reconstitution with donortype cells was achieved in the (6+6) Gy and (6.5+6.5) Gy groups, in contrast to the results using the other protocols. In all the BMT combinations, the rates of graft failure were substantially lower in the groups irradiated with (6+6), (6.5+6.5) or (7+7) Gy than those irradiated with (5+5) or 9.5 Gy ( Figure 5 ). Stable reconstitution to donor-type could be maintained in the mice irradiated with (5+5) to (7+7) Gy for at least 6 months post transplantation (data not shown). These results indicate that FTBI of a total of 12 to 13 Gy with an interval of 4 h the day before BMT is the most effective method for allogeneic BMT in mice.
Differences in survival rates and reconstitution rates between (C3H→B6) and (B6→C3H) chimeric mice
As shown in Figure 3 , a distinct difference in survival rates was observed between (C3H→B6) and (B6→C3H) chim- eric mice irradiated with (2+2) Gy for 3 days: All the (C3H→B6) mice survived for more than 60 days, whereas all the (B6→C3H) mice died within 11 days. In the (C3H→B6) mice, no donor-type cells were detected, indicating that the irradiation dose is not sufficient to remove the recipient cells. There was a significant number of hematolymphoid cells in the BM, spleen and liver of (C3H→B6) mice even 10 days after BMT, but all the cells in these tissues were recipient-type cells (data not shown). Indeed, (C3H→B6) mice that had simply been irradiated ( (2+2) Gy for 3 days) were able to survive without the injection of BMCs. However, in the (B6→C3H) mice, the number of hematolymphoid cells in the BM, spleen and thymus markedly decreased, and the PBC count was less than 1000 7 days after BMT (data not shown). Moreover, no reconstitution was observed in the BM, spleen or liver (data not shown). We therefore examined the cause of early death after BMT in the (B6→C3H) mice. Irradiation with (2+2) Gy for 3 days was not sufficient to fully remove the recipients' immunocompetent cells, since a large number of recipienttype NK and CD4
+ cells were also detected in the PB, spleen and BM of the recipients 7 days after BMT in contrast to the (6.5+6.5) Gy group (Figure 6a ). This observation was further confirmed by the mixed lymphocyte reaction (Figure 6b) . The spleen cells of (B6→C3H) mice (7 days after BMT) in the (6+6) Gy or 9.5 Gy group showed no responses against donor (B6), recipient (C3H) or the third-party (DBA/1) cells. In contrast, the spleen cells of (B6→C3H) mice (7 days after BMT) in the group that received (2+2) Gy for 3 days showed a significantly high response against donor (B6) and third-party (DBA/1) stimulator cells (but not recipient (C3H)-type cells). 
Discussion
Many recent reports show that BM contains not only hemopoietic stem cells (HSCs) but also multi-organ stem cells, which can differentiate into adipocytes, osteoblasts, chondrocytes, myocytes, astrocytes and epithelial cells of the liver, lung and skin. 12 Therefore, BMT is now considered to be an important and useful strategy for the repair of various tissues, and constitutes a multi-functional treatment for various diseases. Accordingly, effective and safe irradiation protocols must be established, because the current irradiation methods are not always successful in the treatment of some diseases.
Efficacy and toxicity of FTBI are affected by three parameters: dose rate, dose fractionation and interval between irradiations. In the present study, the dose rate was fixed at 1.02 Gy/min, because Salomon et al 13 demonstrated that a dose rate less than 0.8 Gy/min could not effectively remove recipient HSCs even if a single high dose (8 Gy) was given in (B6→C3H) mice, and that the survival rate of these mice declined when the dose rate was increased to 1.3 Gy/min. In humans, FTBI, which is delivered in 2-10 fractions separated by 6 to 24 h intervals, is most commonly administered 1-3 and therefore we have examined time intervals of 1 to 24 h in the mouse system. As shown in Figures 1 and 2 , when mice were irradiated with (5+5) Gy, both the survival and reconstitution rates were better with time intervals shorter than 8 h. In contrast, when irradiated with 6 Gy, the survival rate was lower in the 1
Bone Marrow Transplantation to 2 h interval groups, and the cataracts were observed in the 1 h interval group. Although higher survival rates could be achieved in the groups beyond the 8 h interval, the reconstitution rates in the 8 to 24 h groups were lower than in the 4 h group. The difference in survival rates between (5+5) and (6+6) Gy irradiation can be explained as follows: when irradiated with (5+5) Gy at the 14 to 24 h interval, recipient immunocompetent cells are not eliminated completely, since such longer intervals give sufficient time for the damaged cells to be repaired. Recovered immunocompetent cells of the recipients attack the donor-derived cells (the collision of donor-derived and host-derived cells), resulting in death due to infection (graft failure). In contrast, (6+6) Gy irradiation (a high dose) can eliminate the recipient immunocompetent cells completely even if the irradiation interval is prolonged to 14-24 h. Therefore, donor cells can be engrafted in the recipients. However, in the case of short intervals (1-3 h), even (5+5) Gy (which is similar to that of one-shot radiation (9 to 10 Gy)) can cause substantial damage to recipient immunocompetent cells, and hemopoiesis can be therefore reconstituted with donor cells. A (6+6) Gy irradiation at the interval of 1 to 3 h (which is similar to that of one-shot radiation (11 to 12 Gy)) causes damage to not only recipient immunocompetent cells but also other radiosensitive cells such as epithelial cells in the intestine; indeed, cataracts were observed 1 month later, as mentioned above. Moreover, it is generally known that dormant cells of tumor cell lines re-enter the mitotic cycle in vitro 4-6 h after lethal irradiation. Therefore, it is conceivable that the second irradiation at 4 h after the first irradiation effectively removes the immunocompetent cells that have just re-entered the cell cycle from the dormant stage after the first irradiation.
FTBI of 6-6.5 Gy with a 4 h interval appears to be critical for successful BMT in various strain combinations, because a high survival rate could be achieved, and most cells in the peripheral blood and various hematolymphoid tissues of these mice are of the donor type (Figures 3, 4,  5 ). There are some reports investigating the effects of FTBI in allogeneic BMT. [13] [14] [15] [16] Pierce et al 14 reported that three equal fractions within 24 h (total 7 or 9 Gy) is more effective in promoting survival and skin graft than a single dose of irradiation. However, Salomon et al 13 and Soderling et al 15 showed that a single dose of irradiation was more effective than FTBI, although the experimental systems differed substantially from ours. We used whole BMCs (not T celldepleted BMCs 13, 15 ) for transplantation and the dose rates of irradiation in our experiments were five to 10 times higher than in Salomon's experiments. 13 Down et al 16 also reported that two equal TBI (ranging from 3 h to 6 days) requires higher total doses than single-dose irradiation in order to achieve equivalent engraftment, in syngeneic and allogeneic BMT. The dose rate of irradiation (1 Gy/min) in their experiments is similar to ours (1.02 Gy/min). However, the number of injected whole BMCs (10 7 /mouse) in their experiments is rather higher than ours (3 ϫ 10 6 whole BMCs/mouse); in our preliminary experiments, all the mice injected with 10 7 whole BMCs survived and were completely reconstituted.
Our previous study shows that (5+5) Gy rather than a single dose of 9.5 Gy can induce long-term survival in (normal→MRL/lpr) mice. 11 Therefore, FTBI of 5-6.5 Gy with a 4 h interval is universally applicable for not only radiosensitive autoimmune-prone MRL/lpr mice but also standard strains of mice.
In the present study, we found a distinct difference in radiation sensitivity between B6 and C3H mice when these mice were irradiated with (2+2) Gy for 3 days (Figure 3) . It is unlikely that the (B6→C3H) mice died of severe GVHD caused by donor T cells, because no T cell infiltration was observed in recipient tissues, such as the spleen, liver or skin (data not shown). As shown in Figure 6a , no donortype CD4
+ or CD8 + cells were detected in the recipient PB, spleen or BM. Moreover, the survival rate of the (B6→C3H) mice was not prolonged even if T cell-depleted BMCs were injected (data not shown). Figure 6 shows that recipient T cells and NK cells remain and respond to the donor cells. These observations were further confirmed by the observation that the (B6→C3H) mice could be reconstituted when pre-treated with anti-asialo GM1 antibody on day 3 before BMT and the mice were also given 10 7 B6 BMCs on day 0 (data not shown). It is therefore highly probable that remaining immunocompetent cells of the recipient C3H mice attacked the donor (B6) cells, which resulted in the failure of hematolymphoid reconstitution. Although a small number of HSCs likely remain in the recipient C3H mice after insufficient irradiation, unlike the HSCs of B6 mice, C3H HSCs may have no capacity to reconstitute. It is well-known that C3H mice have a shorter lifespan than B6 mice (mean lifespan: C3H-400 and B6-650 days), and that C3H mice have about three times the number of cycling cobblestone area-forming cells (CAFCs) as B6 mice. 17, 18 The difference in radiation sensitivity between the two strains has been mentioned in fundamental works by Roderick 19 and Storer, 20 indicating that the survival of C3H mice decreases to about 70% of B6 mice when exposed daily to a low dose of X-ray irradiation (1 Gy/day). It is therefore possible that the HSCs of C3H mice are more severely damaged than those of B6 mice, and that, as a result, reconstitution of tissues is more severely impeded. Thus, the early death of C3H mice seems to be caused not only by profound tissue damage induced by reciprocal attacks between recipient and donor T and NK cells but also by the inability of remaining HSCs (injured by radiation) of C3H mice to reconstitute the recipient mice. However, it should be noted that such strain differences in irrradiation sensitivity, which emerged only in fractionated low-dose irradiation, can be overcome by two doses of irradiation with a 4 h interval, and that stable reconstitution with donor-type cells can be achieved. In our laboratory, it was recently found that this irradiation protocol is also effective in BMT in rats (data not shown).
The genetically determined differences of C3H and B6 mice in radiation sensitivity, observed in irradiation with (2+2) Gy for 3 days, may explain the dramatically different outcomes observed in human BMT. These findings are important because a similar irradiation protocol is generally now applied to humans.
